Cargando…

Critical limb ischemia in a patient with systemic lupus erythematosus: a case report

BACKGROUND: Peripheral vascular disease is the rarest vascular complication in systemic lupus erythematosus. Some theories propose that immune complexes may promote inflammation in the vessel, and disrupt it in a manner that may cause ischemia. CASE PRESENTATION: A 14-year-old Asian girl presented w...

Descripción completa

Detalles Bibliográficos
Autores principales: Damay, Vito, Wiharja, Wendy, Pranata, Raymond, Aziz, Melisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482571/
https://www.ncbi.nlm.nih.gov/pubmed/31018871
http://dx.doi.org/10.1186/s13256-019-2024-9
_version_ 1783413910282436608
author Damay, Vito
Wiharja, Wendy
Pranata, Raymond
Aziz, Melisa
author_facet Damay, Vito
Wiharja, Wendy
Pranata, Raymond
Aziz, Melisa
author_sort Damay, Vito
collection PubMed
description BACKGROUND: Peripheral vascular disease is the rarest vascular complication in systemic lupus erythematosus. Some theories propose that immune complexes may promote inflammation in the vessel, and disrupt it in a manner that may cause ischemia. CASE PRESENTATION: A 14-year-old Asian girl presented with intermittent claudication as the chief complaint followed by discoloration of her left big toe for 2 weeks prior to admission. Her medical history showed that 1 month prior to admission she had photosensitivity, rash, and arthralgia, with positive antinuclear antibody test, positive anti-double-stranded DNA test, positive anti-ribosomal protein P, and complement C4 (7.4 mg/dL); she was diagnosed as having systemic lupus erythematosus and started therapy. A local examination of her left toe showed black discoloration, low pulsation, localized tenderness, and decreased sensation. Laboratory results showed C-reactive protein of 1.16 mg/dL and D-dimer of 2.28 uG/mL. A computed tomography angiogram showed near total occlusion of her popliteal artery; critical limb ischemia was confirmed. Peripheral arteriography was performed with invasive strategy. After the procedure, the flow was improved to distal, but there was inflammation in the vessel, so we decided to stop the procedure because of the risk of dissection. Our patient was given atorvastatin and warfarin, and we maximized her systemic lupus erythematosus therapy with prednisone. There were two follow-ups. The first follow-up was 1 week after the procedure. Our patient attended her first follow-up at our out-patient department with no symptoms and improvement in her toe’s discoloration; warfarin was stopped, and clopidogrel and cilostazol were added for thrombus prevention therapy, she was then scheduled for debridement. The second follow-up was done 2 months after the first follow-up and discoloration was improved. The third follow-up, 5 months after the second follow-up, showed improvement. CONCLUSION: Critical limb ischemia is a rare complication of systemic lupus erythematosus that requires immediate treatment. Due to our limited resources, we improvised a strategy to achieve the best possible outcome in our patient by using a combination of invasive treatment and medication.
format Online
Article
Text
id pubmed-6482571
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64825712019-05-02 Critical limb ischemia in a patient with systemic lupus erythematosus: a case report Damay, Vito Wiharja, Wendy Pranata, Raymond Aziz, Melisa J Med Case Rep Case Report BACKGROUND: Peripheral vascular disease is the rarest vascular complication in systemic lupus erythematosus. Some theories propose that immune complexes may promote inflammation in the vessel, and disrupt it in a manner that may cause ischemia. CASE PRESENTATION: A 14-year-old Asian girl presented with intermittent claudication as the chief complaint followed by discoloration of her left big toe for 2 weeks prior to admission. Her medical history showed that 1 month prior to admission she had photosensitivity, rash, and arthralgia, with positive antinuclear antibody test, positive anti-double-stranded DNA test, positive anti-ribosomal protein P, and complement C4 (7.4 mg/dL); she was diagnosed as having systemic lupus erythematosus and started therapy. A local examination of her left toe showed black discoloration, low pulsation, localized tenderness, and decreased sensation. Laboratory results showed C-reactive protein of 1.16 mg/dL and D-dimer of 2.28 uG/mL. A computed tomography angiogram showed near total occlusion of her popliteal artery; critical limb ischemia was confirmed. Peripheral arteriography was performed with invasive strategy. After the procedure, the flow was improved to distal, but there was inflammation in the vessel, so we decided to stop the procedure because of the risk of dissection. Our patient was given atorvastatin and warfarin, and we maximized her systemic lupus erythematosus therapy with prednisone. There were two follow-ups. The first follow-up was 1 week after the procedure. Our patient attended her first follow-up at our out-patient department with no symptoms and improvement in her toe’s discoloration; warfarin was stopped, and clopidogrel and cilostazol were added for thrombus prevention therapy, she was then scheduled for debridement. The second follow-up was done 2 months after the first follow-up and discoloration was improved. The third follow-up, 5 months after the second follow-up, showed improvement. CONCLUSION: Critical limb ischemia is a rare complication of systemic lupus erythematosus that requires immediate treatment. Due to our limited resources, we improvised a strategy to achieve the best possible outcome in our patient by using a combination of invasive treatment and medication. BioMed Central 2019-04-25 /pmc/articles/PMC6482571/ /pubmed/31018871 http://dx.doi.org/10.1186/s13256-019-2024-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Damay, Vito
Wiharja, Wendy
Pranata, Raymond
Aziz, Melisa
Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title_full Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title_fullStr Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title_full_unstemmed Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title_short Critical limb ischemia in a patient with systemic lupus erythematosus: a case report
title_sort critical limb ischemia in a patient with systemic lupus erythematosus: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482571/
https://www.ncbi.nlm.nih.gov/pubmed/31018871
http://dx.doi.org/10.1186/s13256-019-2024-9
work_keys_str_mv AT damayvito criticallimbischemiainapatientwithsystemiclupuserythematosusacasereport
AT wiharjawendy criticallimbischemiainapatientwithsystemiclupuserythematosusacasereport
AT pranataraymond criticallimbischemiainapatientwithsystemiclupuserythematosusacasereport
AT azizmelisa criticallimbischemiainapatientwithsystemiclupuserythematosusacasereport